These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 8821579)
1. Interleukin-6: a comprehensive review. Lotz M Cancer Treat Res; 1995; 80():209-33. PubMed ID: 8821579 [No Abstract] [Full Text] [Related]
2. Structure and function of interleukin-4 and its receptor. Puri RK Cancer Treat Res; 1995; 80():143-85. PubMed ID: 8821577 [No Abstract] [Full Text] [Related]
3. Interleukin-7 and lymphopoiesis: biological and clinical implications. Appasamy PM Cancer Treat Res; 1995; 80():235-60. PubMed ID: 8821580 [No Abstract] [Full Text] [Related]
4. Interleukin-6: biologic properties and role in lymphoproliferative disorders. Seymour JF; Kurzrock R Cancer Treat Res; 1996; 84():167-206. PubMed ID: 8724631 [No Abstract] [Full Text] [Related]
5. Cytokine signal transduction through a homo- or heterodimer of gp130. Kishimoto T; Tanaka T; Yoshida K; Akira S; Taga T Ann N Y Acad Sci; 1995 Sep; 766():224-34. PubMed ID: 7486664 [No Abstract] [Full Text] [Related]
6. Regulation of terminal differentiation of human B-cells by IL-6. Chen-Kiang S Curr Top Microbiol Immunol; 1995; 194():189-98. PubMed ID: 7895492 [No Abstract] [Full Text] [Related]
7. A novel leukocyte chemotactic and activating cytokine, interleukin-8 (IL-8). Mukaida N; Harada A; Matsushima K Cancer Treat Res; 1995; 80():261-86. PubMed ID: 8821581 [No Abstract] [Full Text] [Related]
8. [Cytokine binding proteins: a model of interleukin 6]. Brailly H; Montero-Julian FA Arch Inst Pasteur Tunis; 1994; 71(3-4):535-48. PubMed ID: 8801856 [No Abstract] [Full Text] [Related]
9. Interleukin-12: a pivotal regulator of cell-mediated immunity. Gately MK; Brunda MJ Cancer Treat Res; 1995; 80():341-66. PubMed ID: 8821585 [No Abstract] [Full Text] [Related]
10. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Peters M; Müller AM; Rose-John S Blood; 1998 Nov; 92(10):3495-504. PubMed ID: 9808540 [No Abstract] [Full Text] [Related]
11. Interleukin-11 (IL-11) and its receptor: biology and potential clinical applications in thrombocytopenic states. Yang YC Cancer Treat Res; 1995; 80():321-40. PubMed ID: 8821584 [No Abstract] [Full Text] [Related]
12. Early response genes activated by stimulation of human B lymphocytes through different cell surface receptors. Newton JS; Li J; Ning ZQ; Norton JD; Murphy JJ Biochem Soc Trans; 1996 Feb; 24(1):7S. PubMed ID: 8674747 [No Abstract] [Full Text] [Related]
13. Antitumor and antimetastatic activity of interleukin-12. Hendrzak JA; Brunda MJ Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():65-83. PubMed ID: 8815011 [No Abstract] [Full Text] [Related]
15. Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)-binding sites of the human IL-6 receptor. Kalai M; Montero-Julian FA; Grötzinger J; Wollmer A; Morelle D; Brochier J; Rose-John S; Heinrich PC; Brailly H; Content J Eur J Biochem; 1996 Jun; 238(3):714-23. PubMed ID: 8706672 [TBL] [Abstract][Full Text] [Related]
16. Current concepts of B cell modulation. Matsuda T; Yamasaki K; Taga T; Hirano T; Kishimoto T Int Rev Immunol; 1989; 5(2):97-109. PubMed ID: 8691054 [TBL] [Abstract][Full Text] [Related]
17. Gp130 in human myeloma/plasmacytoma. Tani Y; Nishimoto N; Ogata A; Shima Y; Yoshizaki K; Kishimoto T Curr Top Microbiol Immunol; 1995; 194():229-33. PubMed ID: 7895494 [No Abstract] [Full Text] [Related]
18. Interleukin-5: an overview. Takatsu K Cancer Treat Res; 1995; 80():187-208. PubMed ID: 8821578 [No Abstract] [Full Text] [Related]
19. Membrane-bound and soluble interleukin-6 receptor: studies on structure, regulation of expression, and signal transduction. Heinrich PC; Graeve L; Rose-John S; Schneider-Mergener J; Dittrich E; Erren A; Gerhartz C; Hemann U; Lütticken C; Wegenka U Ann N Y Acad Sci; 1995 Jul; 762():222-36; discussion 236-7. PubMed ID: 7545364 [No Abstract] [Full Text] [Related]